Abstract
Individuals with 5α-reductase-2 deficiency (5α-RD-2) and 17β-hydroxysteroid dehydrogenase-3 deficiency (17β-HSD-3) are often raised as girls. Over the past number of years, this policy has been challenged because many individuals with these conditions develop a male gender identity and make a gender role change after puberty. The findings also raised doubts regarding the hypothesis that children are psychosexually neutral at birth and emphasized the potential role of prenatal brain exposure to androgens in gender development. If prenatal exposure to androgens is a major contributor to gender identity development, one would expect that all, or nearly all, affected individuals, even when raised as girls, would develop a male gender identity and make a gender role switch later in life. However, an estimation of the prevalence of gender role changes, based on the current literature, shows that gender role changes occur frequently, but not invariably. Gender role changes were reported in 56–63% of cases with 5α-RD-2 and 39–64% of cases with 17β-HSD-3 who were raised as girls. The changes were usually made in adolescence and early adulthood. In these two syndromes, the degree of external genital masculinization at birth does not seem to be related to gender role changes in a systematic way.
Similar content being viewed by others
References
Aguilar-Diosdado, M., Gavilán-Villarejo, I., Escobar-Jiménez, L., Beltrán, J., & Girón, J. A. (1995). Male pseudohermaphroditism with 5-α-reductase deficiency: Report of two new familial cases. The importance of early diagnosis. Journal of Pediatric Endocrinology and Metabolism, 8, 67–71.
Akesode, F. A., Meyer, W. J., & Migeon, C. J. (1977). Male pseudohermaphroditism with gynaecomastia due to testicular 17-ketosteroid reductase deficiency. Clinical Endocrinology, 7, 443–452.
Akgun, S., Ertel, N. H., Imperato-McGinley, J., Sayli, B. S., & Shackleton, C. (1986). Familial male pseudohermaphroditism due to 5-alpha-reductase deficiency in a Turkish village. American Journal of Medicine, 81, 267–274.
Al-Attia, H. M. (1996). Gender identity and role in a pedigree of Arabs with intersex due to 5 alpha reductase-2 deficiency. Psychoneuroendocrinology, 21, 651–657.
Andersson, S., Geissler, W. M., Wu, L., Davis, D. L., Grumbach, M. M., New, M. I., et al. (1996). Molecular genetics and pathophysiology of 17 β-hydroxysteroid dehydrogenase 3 deficiency. Journal of Clinical Endocrinology and Metabolism, 81, 130–136.
Balducci, R., Toscano, V., Wright, F., Bozzolan, F., Di Piero, G. Maroder, M., et al. (1985). Familial male pseudohermaphroditism with gynaecomastia due to testicular 17-ketosteroid reductase deficiency. A report of 3 cases. Clinical Endocrinology, 23, 439–444.
Bartsch, G., Decristoforo, A., & Schweigert, U. (1987). Pseudovaginal perineoscrotal hypospadias: Clinical, endocrinological and biochemical characterization of a patient. European Urology, 13, 386–389.
Boudon, C., Lumbroso, S., Lobaccaro, J. M., Szarras-Czapnik, M., Romer, T. E., Garandeau, P., et al. (1995). Molecular study of the 5 α-reductase type 2 gene in three European families with 5α-reductase deficiency. Journal of Clinical Endocrinology and Metabolism, 80, 2149–2153.
Canto, P., Vilchis, F., Chávez, B., Mutchinick, O., Imperato-McGinley, J., Pérez-Palacios, G., et al. (1997). Mutations of the 5α-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5α-reductase-2 deficiency. Clinical Endocrinology, 46, 155–160.
Cantú, J. M., Corona-Rivera, E., Díaz, M., Medina, C., Esquinca, E., Cortés-Gallegos, V., et al. (1980). Post-pubertal female psychosexual orientation in incomplete male pseudohermaphroditism type 2 (5α-reductase deficiency). Acta Endocrinologica, 94, 273–279.
Cantú, J. M., Hernández-Montes, H., del Gastillo, V., Cortés-Gallegos, V., Sandoval, R., Armendares, S., et al. (1976). Potential fertility in incomplete male pseudohermaphroditism type 2. Revista de Investigacion Clinica, 28, 177–182.
Chávez, B., Valdez, E., & Vilchis, F. (2000). Uniparental disomy in steroid 5α-reductase 2 deficiency. Journal of Clinical Endocrinology and Metabolism, 85, 3147–3150.
Corrall, R. J. M., Wakelin, K., O’Hare, J. P., O’Brien, I. A. D., Ishmail, A. A. A., & Honour, J. (1984). 5α-reductase deficiency: Diagnosis via abnormal plasma levels of reduced testosterone derivatives. Acta Endocrinologica, 107, 538–543.
Deslypere, J. P., Coucke, W., Robbe, N., & Vermeulen, A. (1985). 5α-reductase deficiency: An infrequent cause of male pseudohermaphroditism. Acta Clinica Belgica, 40, 240–245.
Ferraz, L. F. C., Guerra, G., Baptista, M. T. M., Maciel-Guerra, A. T., & Hackel, C. (1998). Detection of Gly-196-ser mutation in 5α-reductase type 2 gene in a Brazilian patient with female assignment and behavior. Journal of Pediatric Endocrinology and Metabolism, 11, 465–466.
Ferraz, L. F. C., Baptista, M. T. M., Maciel-Guerra, A. T., Guerra, G., Junior, G. G., & Hackel, C. (1999). New frameshift mutation in the 5α-reductase type II gene in a Brazilian patient with 5α-reductase deficiency. American Journal of Medical Genetics, 87, 221–225.
Fisher, L. K., Kogut, M. D., Moore, R. J., Goebbelsmann, U., Weitzman, J. J., Isaacs, H., et al. (1978). Clinical, endocrinological, and enzymatic characterization of two patients with 5α-reductase deficiency: Evidence that a single enzyme is responsible for the 5α-reduction of cortisol and testosterone. Journal of Clinical Endocrinology and Metabolism, 47, 653–664.
Forti, G., Falchetti, A., Santoro, S., Davis, D. L., Wilson, J. D., & Russel, D. W. (1996). Steroid 5α-reductase 2 deficiency: Virilization in early infancy may be due to partial function of mutant enzyme. Clinical Endocrinology, 44, 477–482.
Gajdusek, D. C. (1977). Urgent opportunistic observations: The study of changing, transient and disappearing phenomena of medical interest in disrupted primitive human communities. In Health and disease in tribal societies. CIBA Symposium 49 (New Series, pp. 69–102). Amsterdam: Elsevier/Excerpta Medica.
Hedia, S., Mohammed, S., Insaf, H. A., Houda, G., Yamina, F., Myrvat, K., et al. (2001). Male pseudo-hermaphroditism due to a partial 5α-reductase deficiency: A case report. Tunis Medicine, 79, 261–265.
Herdt, G. H., & Davidson, J. D. (1988). The Sambia “Turnim-man”: Sociocultural and clinical aspects of gender formation in male pseudohermaphrodites with 5-alpha-reductase deficiency in Papua New Guinea. Archives of Sexual Behavior, 17, 33–56.
Hochberg, Z., Chayen, R., Reiss, N., Falik, Z., Makler, A., Munichor, M., et al. (1996). Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5α-reductase 2 deficiency. Journal of Clinical Endocrinology and Metabolism, 81, 2821–2827.
Hodgins, M. B., Clayton, R. N., & London, D. R. (1971). Androgen metabolism and binding in skin fibroblasts from a case of incomplete male pseudohermaphroditism. Journal of Endocrinology, 75, 24.
Hurtig, A. L. (1992). The psychosocial effects of ambiguous genitalia. Comprehensive Therapy, 18, 22–25.
Imperato-McGinley, J., Akgun, S., Ertel, N. H., Sayli, B., & Shackleton, C. (1987). The coexistence of male pseudohermaphrodites with 17-ketosteroid reductase deficiency and 5α-reductase deficiency within a Turkish kindred. Clinical Endocrinology, 27, 135–143.
Imperato-McGinley, J., Guerrero, L., Gautier, T., & Peterson, R. E. (1974). Steroid 5α-reductase deficiency in man: An inherited form of male pseudohermaphroditism. Science, 186, 1213–1215.
Imperato-McGinley, J., Miller, M., Wilson, J. D., Peterson, R. E., Shackleton, C., & Gajdusek, D. C. (1991). A cluster of male pseudohermaphrodites with 5α-reductase deficiency in Papua New Guinea. Clinical Endocrinology, 34, 293–298.
Imperato-McGinley, J., Peterson, R. E., Gautier, T., & Sturla, E. (1979). Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5α-reductase deficiency. New England Journal of Medicine, 300, 1233–1237.
Imperato-McGinley, J., Peterson, R. E., Stoller, R., & Goodwin, W. E. (1979). Male pseudohermaphroditism secondary to 17 β-hydroxysteroid dehydrogenase deficiency: Gender role change with puberty. Journal of Endocrinology and Metabolism, 49, 391–395.
Imperato-McGinley, J., Peterson, R. E., Leshin, M., Griffin, J. E., Cooper, G., Draghi, S., et al. (1980). Steroid 5α-reductase deficiency in a 65-year-old male pseudohermaphrodite: The natural history, ultrastructure of the testes, and evidence for inherited enzyme heterogeneity. Journal of Clinical Endocrinology and Metabolism, 50, 15–22.
Ivarsson, S. A., Nielsen, M. D., & Lindberg, T. (1988). Male pseudohermaphroditism due to 5α-reductase deficiency in a Swedish family. European Journal of Pediatrics, 147, 532–535.
Kohn, G., Lasch, E. E., El-Shawwa, E., Elrayyes, E., Litvin, Y., & Rösler, A. (1985). Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency (17β-HSD) in a large Arab kinship: Studies on the natural history of the defect. Journal of Pediatric Endocrinology, 1, 29–37.
Kuttenn, F., Mowszowicz, I., Wright, F., Baudot, N., Jaffiol, C., Robin, M., et al. (1979). Male pseudohermaphroditism: A comparative study of one patient with 5α-reductase deficiency and three patients with the complete form of testicular feminization. Journal of Clinical Endocrinology and Metabolism, 45, 861–865.
Lanes, R., Brown, T. R., Gruber de Bustos, E., Valverde, B., Pieretti, R. B., Bianco, N., et al. (1983). Sibship with 17-ketosteroid reductase (17-KSR) deficiency and hypothyroidism: Lack of linkage of histocompatibility leucocyte antigen and 17-KSR loci. Journal of Clinical Endocrinology and Metabolism, 5, 190–196.
Leinonen, P., Dunkel, L., Perheentupa, L., & Vihko, R. (1983). Male pseudohermaphroditism due to deficiency of testicular 17-ketosteroid reductase. Acta Paediatrica Scandinavica, 72, 211–214.
Mauvais-Jarvis, P., Kuttenn, F., Mowszowicz, I., & Wright, F. (1981). Different aspects of 5α-reductase deficiency in male pseudohermaphroditism and hypothyroidism. Clinical Endocrinology, 14, 459–469.
Mazen, I., Gad, Y. Z., Hafez, M., Sultan, C., & Lumbroso, S. (2003). Molecular analysis of 5-α reductase type 2 gene in eight unrelated Egyptian children with suspected 5α-reductase deficiency: Prevalence of the G34R mutation. Clinical Endocrinology, 58, 627–631.
Méndez, J. P., Ullora-Aguirre, A., Imperato-McGinley, J., Brugmann, A., Delfin, M., Chávez, B., et al. (1995). Male pseudohermaphroditism due to primary 5α-reductase deficiency: Variation in gender identity reversal in seven Mexican patients from five different pedigrees. Journal of Endocrinological Investigations, 18, 205–213.
Mendonca, B. B., Inacio, M., Arnhold, I. J. P., Costa, E. M. F., Bloise, W., Martin, R. M., et al. (2000). Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase 3 deficiency. Medicine, 79, 299–309.
Mendonca, B. B., Inacio, M., Costa, E. M. F. Arnhold, I. J. P., Russell, D. W., & Wilson, J. D. (2003). Male pseudohermaphroditism due to 5α-reductase 2 deficiency: Outcome of a Brazilian cohort. The Endocrinologist, 13, 201–204.
Mendonca, B. B., Inacio, M., Costa, E. M. F., Arnhold, I. J. P., Silva, F. A. Q., Russell, D. W., et al. (1996). Male pseudohermaphroditism due to steroid 5α-reductase deficiency: Diagnosis, psychological evaluation, and management. Medicine, 75, 64–76.
Millán, M., Audi, L., Martinez-Mora, J., Martinez de Osaba, M. J., Viguerra, J., Esmatjes, E., et al. (1983). 17-Ketosteroid reductase deficiency in an adult patient without gynaecomastia but with female psychosexual orientation. Acta Endocrinologica, 102, 633–640.
Money, J. (1979). [Letter to the editor]. Obstetrical and Gynecological Survey, 34, 770–771.
Nordenskjöld, A., Magnus, O., Aagenaes, O., & Knudtzon, J. (1998). Homozygous mutation (A228T) in the 5α-reductase type 2 gene in a boy with 5α-reductase deficiency: Genotype-phenotype correlations. American Journal of Medical Genetics, 80, 269–272.
Okon, E., Livni, N., Rösler, A., Yorkoni, S., Segal, S., Kohn, G., et al. (1980). Male pseudohermaphroditism due to 5α-reductase deficiency: Ultrastructure of the gonads. Archives of Pathology and Laboratory Medicine, 104, 363–367.
Park, D., Lee, P. A., & Witchel, S. F. (1996). Progressive virilization of a pubertal phenotypic female: 17β-hydroxysteroid dehydrogenase deficiency. Journal of Pediatric and Adolescent Gynecology, 9, 9–11.
Price, P., Wass, J. A., Griffin, J. E., Leshin, M., Savage, M. O., Large, D. M., et al. (1984). High dose androgen therapy in male pseudohermaphroditism due to 5α-reductase deficiency and disorders of the androgen receptor. Journal of Clinical Investigation, 74, 1496–1508.
Punnose, J., Mathew, K. S., & Ahmed, H. F. (1995). 5-alpha-reductase deficiency in a Saudi ‘girl.’ Postgraduate Medical Journal, 71, 701.
Rösler, A. (1992). Steroid 17β-hydroxysteroid dehydrogenase deficiency in man: An inherited form of male pseudohermaphroditism. Journal of Steroid Biochemistry and Molecular Biology, 43, 989–1002.
Rösler, A., & Kohn, G. (1983). Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency: Studies on the natural history of the defect and effect of androgens on gender role. Journal of Steroid Biochemistry, 19, 663–674.
Rösler, A., Silverstein, S., & Abeliovich, D. (1996). A (R80Q) mutation in 17 β-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. Journal of Clinical Endocrinology and Metabolism, 81, 1827–1831.
Saenger, P., Goldman, A., Levine, L. S., Korth-Schutz, S. Muecke, E. C., Katsumata, M., et al. (1978). Prepubertal diagnosis of steroid 5α-reductase deficiency. Journal of Clinical Endocrinology and Metabolism, 46, 627–634.
Saez, J. M., de Peretti, E., Morera, A. M., David, M., & Bertrand, J. (1970). Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo. Clinical Endocrinology, 32, 604–610.
Savage, M. O., Preece, M. A., Jeffcoate, S. L., Ransley, P. G., Rumsby, G., Mansfield, M. D., et al. (1980). Familial male pseudohermaphroditism due to deficiency of 5α-reductase. Clinical Endocrinology, 12, 397–406.
Sinnecker, G. H. G., Hiort, O., Dibbelt, L., Albers, N., Dörr, H. G., Hauss, H., et al. (1996). Phenotypic classification of male pseudohermaphroditism due to steroid 5α-reductase 2 deficiency. American Journal of Medical Genetics, 63, 223–230.
Sobel, V., & Imperato-McGinley, J. (2004). Gender identity in XY intersexuality. Child and Adolescent Psychiatric Clinics of North America, 13, 609–622.
Stoller, R. J. (1985). Presentations of gender. New Haven, CT: Yale University Press.
Virdis, R., Saenger, P., Senior, B., & New, M. I. (1978). Endocrine studies in a pubertal male pseudohermaphrodite with 17-ketosteroid reductase deficiency. Acta Endocrinologica, 87, 212–224.
Walden, U., Rauch, R., Hiort, O., Sinnecker, G. H. G., & Dörr, H. G. (1998). Diagnosis of 5α-reductase deficiency in a teenage Turkish girl. Journal of Pediatric and Adolescent Gynecology, 11, 39–42.
Walsh, P. C., Madden, J. D., Harrod, M. J., Goldstein, J. L. MacDonald, P. C., & Wilson, J. D. (1974). Familial incomplete male pseudohermaphroditism, type 2: Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. New England Journal of Medicine, 291, 944–949.
Wieacker, P., Flecken, U., & Breckwoldt, M. (1992). Ein Fall von pseudovaginaler, perineoskrotaler Hypospadie mit 5α-Reduktase-Defizienz [A case of pseudovaginal, perineoscrotal Oypospadias with 5α-reductase deficiency]. Geburtshilfe und Frauenheilkunde, 52, 126–128.
Wieacker, P., & Von Mühlendahl, K. E. (1996). Störung der 17β-Hydroxysteroid-Dehydrogenase als Ursache eines hypergonadotropen Hypogonadismus bei zwei Geschwistern mit primärer Amenorrhö. Geburtshilfe und Frauenheilkunde, 56, 491–493.
Wilson, J. D. (2001). Androgens, androgen receptors, and male gender role behavior. Hormones and Behavior, 40, 358–366.
Wilson, S. C., Hodgins, M. B., & Scott, J. S. (1987). Incomplete masculinization due to a deficiency of 17β-hydroxysteroid dehydrogenase: Comparison of prepubertal and peripubertal siblings. Clinical Endocrinology, 26, 459–469.
Yücel, B., & Polat, A. (2003). A late sex reassignment in 5-α reductase deficiency: Case report. International Psychiatry Medicine, 33, 189–193.
Zucker, K. J. (1999). Intersexuality and gender identity differentiation. Annual Review of Sex Research, 10, 1–69.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cohen-Kettenis, P.T. Gender Change in 46,XY Persons with 5α-Reductase-2 Deficiency and 17β-Hydroxysteroid Dehydrogenase-3 Deficiency. Arch Sex Behav 34, 399–410 (2005). https://doi.org/10.1007/s10508-005-4339-4
Issue Date:
DOI: https://doi.org/10.1007/s10508-005-4339-4